APA (7th ed.) Citation

K, H., J, I., K, H., M, H., Y, B., M, M., . . . K, Y. (2023). Turicibacter and Acidaminococcus predict immune-related adverse events and efficacy of immune checkpoint inhibitor. Frontiers in immunology, 14, 1164724. https://doi.org/10.3389/fimmu.2023.1164724

Chicago Style (17th ed.) Citation

K, Hamada, et al. "Turicibacter and Acidaminococcus Predict Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitor." Frontiers in Immunology 14 (2023): 1164724. https://doi.org/10.3389/fimmu.2023.1164724.

MLA (9th ed.) Citation

K, Hamada, et al. "Turicibacter and Acidaminococcus Predict Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitor." Frontiers in Immunology, vol. 14, 2023, p. 1164724, https://doi.org/10.3389/fimmu.2023.1164724.